正在加载 ETF 研究
正在获取最新的基金概况、持仓和市场数据。
New York Stock Exchange Arca · Leveraged/Inverse
US$80.55
−US$6.98 · -7.97%
· 8月24日 15:45 ET
US$80.55
常规交易时段−US$6.98 · -7.97%
· 8月24日 15:45 ET
US$80.73
−US$6.80 · -7.77%
盘中时间采用ET。市场数据可能有所延迟。
The MRNX fund is designed to generate returns by taking a leveraged, bullish stance on the daily share price movements of Moderna, Inc. (MRNA). It achieves this primarily through the use of swap agreements and short-term listed call options. Its objective is to deliver a daily return equivalent to 200% (twice) the daily percentage change in MRNA's stock price, which it maintains through daily rebalancing. However, holding the fund for periods exceeding a single day may lead to actual returns that deviate significantly from this 2x daily target, influenced by factors like market volatility, compounding, and rebalancing impacts. For collateral supporting its derivative contracts, MRNX may also invest in stable assets such as U.S. government securities, money market funds, short-term bond exchange-traded funds (ETFs), and investment-grade corporate debt.
基金资产
2630.47万 USD
费用率
1.31%
NAV
US$87.68
平均成交量
10.73万
成交量
67.87万
当日区间
US$69.50 – US$87.30
52 周区间
US$14.95 – US$143.84
前收盘价
US$87.53
价格变动
1 天
-7.97%
1 个月
+238.16%
3 个月
+287.07%
年初至今
+295.24%
1 年
+295.24%
3 年
+295.24%
5 年
+295.24%
价格变动不包括分派、费用、税费及投资者特定的现金流。
投资组合
持仓数据更新于 2026年8月24日。
最新报道
更多基金
在 GoAI 中继续
结合更广泛的市场背景，在 GoAI 中继续研究此 ETF。
ETF 数据可能延迟、不完整或被修订。持仓和敞口会随时间变化。历史表现不保证未来结果。本页面仅供信息和教育用途，不构成投资建议或推荐。
